PPT-Medicines Optimisation SE London asthma and COPD guidelines

Finlay Royle Senior Clinical Commissioning Pharmacist Lambeth CCG 1 Medicines Optimisation Key theme Quality Safety and Medicines W aste 2 Medicines are the most common therapeutic intervention in healthcare but their use is often . By Laura Parker. Learning Objectives. To be able to define Asthma and COPD. To have an understanding of the pathogenesis of each disease and the common causes / risk factors associated. To be able to recognise the presentation of patient with Asthma or COPD. Some highlights. How the lungs work. 2. What is asthma. Sensitive airways . Inflammation . and swelling. More mucus produced. Airways become narrow. Muscles tighten around airways. Breathing is difficult. Asthma and COPD. Definition of asthma. 2. Working definition by AAH 2014:. Chronic lung disease. Can be controlled not cured. Large variation in lung function. Large variation in respiratory symptoms. Medicines . . Andy Cooke . MRPharmS. Assistant Director, . Head of Medicines Management. Medicines optimisation. ‘Helping patients to make the most of medicines’.  .  . £500m. Principles of Medicines Optimisation. Lauren Clark . Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. SDMH EMC 2015. 1 - Asthma. Objectives. Understand assessment of acute asthma in adults. Outline management strategy dependent upon severity. Approach to initial management of the severe asthmatic. Safe discharge of the asthmatic patient. Alison . Portes. FY1. Objectives. Main features of asthma and COPD. Focus on clinicals – history, examination, investigations, management. 10 minutes on each . Quiz and summary of key points. A few added extras…. Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Dr Rickbir Singh Randhawa. FY1. Definition:. Asthma. Chronic inflammatory airway disease characterised by . reversible airway obstruction. , airway hyper-responsiveness and bronchial inflammation. . Three factors contribute to reversible airway narrowing:. Updates inLaura Vaughan MDClinical Assistant Professor of MedicineStanford UniversityGINA slides used in this presentation are reproduced with permissionNo financial disclosuresSerious Consequences98 Goals. Recognize common and uncommon presentations of COPD and asthma.. Make an appropriate assessment of the severity of illness.. Prescribe appropriate therapy. . Disposition the patient appropriately.. Hetal . Dhruve. . Chandra Sarkar. Aims. Overview of spirometry and . interpretion. . Treatment of COPD . COPD Care plans. Questions . Why spirometry?. Discrepancy . in prevalence of COPD from . rightcare. Dr Victor Duong. Senior Medical Registrar. Northern Health. Asthma. Overview. Initial assessment and management in the ED. Inpatient management. Preparing for discharge. What is not covered. Diagnostic aspects. Eric L. Olson MD, MSc, FCCP. Definition of Asthma. . A disease characterized by the following:. Airway obstruction that is reversible. Airway Inflammation. Increased airway responsiveness to a variety of stimuli.